Complement Therapeutics
Complement Therapeutics
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) | Geographic Atrophy Secondary to Age-related Macular Degeneration | Recruiting | Phase 1 / Phase 2 | 2026-10-08 | NCT07392255 | |
| A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) | Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Not stated | 2026-10-08 | NCT07144137 | |
| Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study | Eye Diseases, Hereditary, Geographic Atrophy, Skin Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, eye disorder, macular degeneration, primary anetoderma, retinal degeneration, retinal disorder, skin disorder | Active, not recruiting | Not stated | 2025-06-13 | NCT05797896 |